Cyclopentanoindoles, compositions containing such compounds and methods of treatment

Details for Australian Patent Application No. 2001277430 (hide)

International Classifications

Event Publications

16 March 2006 Assignment before Grant

Merck Frosst Canada & Co. The application has been assigned to Merck Frosst Canada Ltd.

25 May 2006 Application Accepted

Published as AU-B-2001277430

21 September 2006 Standard Patent Sealed

31 July 2008 Extension of Term of Standard Patents

Merck Frosst Canada Ltd. The earliest first regulatory approval date provided by the patentee 04 Dec 2007 For the goods Cordaptive ER nicotinic Acid/ Laropiprant

14 August 2008 Extension of Term of Standard Patents

Merck Frosst Canada Ltd. The earliest first regulatory approval date provided by the patentee 04 Dec 2007 For the goods Cordaptive ER nicotinic Acid/ Laropiprant Address for service in Australia: Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

15 January 2009 Extension granted

Merck Frosst Canada Ltd. The earliest first regulatory approval date provided by the patentee 04 Dec 2007 For the goods Cordaptive ER nicotinic Acid/ Laropiprant Extension of Term of patent pursuant to Section 77 expires on 04 Dec 2022

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.